ChemoSen3D provides an innovative approach to personalized treatment that combines our proprietary cell-based functional assays with the assets of genetic testing to deliver a comprehensive treatment recommendation based entirely on a patient’s individual response and characteristics.
ChemoSen3D, Inc. (c3D) is an industry innovator in biotechnology, who will use its magnetic 3D bioprinting technology to develop personalized diagnostic testing to guide physicians in choosing the most effective, safe, and personalized treatment for their patients.
We are providing a new approach to personalized treatment that combines the current assets of genetic testing with cell based functional testing to deliver a comprehensive treatment recommendation based entirely on individualized functional response.
“We aim to revolutionize how physicians select a drug for cancer treatment by driving our assay towards Point of Care.”
3D Cell Culture • Biotechnology • Clinical Diagnostics • Nanoparticles